Hong Kong has suspended administering BioNTech’s Covid-19 inoculation, in a move that threatens to further slow the pace of the city’s sluggish vaccine rollout and delay the easing of travel restrictions.
Macau, the Chinese territory near Hong Kong, also halted its BioNTech vaccine drive, citing packaging defects with a batch of the shot distributed in both cities by Fosun Pharma.
The Hong Kong government said the defects were related to the caps that closed the vial bottles.
您已閱讀17%（478字），剩餘83%（2367字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。